Validity of the UK early access to medicines scheme criteria for Remdesivir use in patients with COVID-19 disease. (2020)

First Author: Daunt A
Attributed to:  MRC Centre for Global Infectious Disease Analysis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jinf.2020.06.049

PubMed Identifier: 32579980

Publication URI: http://europepmc.org/abstract/MED/32579980

Type: Journal Article/Review

Volume: 81

Parent Publication: The Journal of infection

Issue: 4

ISSN: 0163-4453